In This Week’s Issue:
 
1. PIPC Chairman Applauds NCD Efforts to Combat Discriminatory Health Care Policies, click here to read the letter.
2. National Health Council and Tufts Launch New Patient-Centered Value Assessment Initiative, click here to learn more.
3. Mom of Child with SMA Testifies Before Congress, see details below.
4. Amplifying the Voices of Alzheimer’s, see details below.
5. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
6. Emerging Threats in States like CO and ME for Use of Discriminatory Metrics, see details below.
7. IVI to Hold Second Methods Summit, click here to learn more.
8. Vaccination Equity and Communication, see details below.
9. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
10. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Alzheimer's Disease, Asthma, click here to provide patient input.
11. Upcoming Events and Webinars, see details below.
12. Medical Journal Articles, see details below.
13. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:

1. National Health Council and Tufts Launch New Patient-Centered Value Assessment Initiative, click here to learn more.
2. PIPC Chairman Applauds NCD Efforts to Combat Discriminatory Health Care Policies, click here to read the letter.
3. Mom of Child with SMA Testifies Before Congress, see details below.
4. Amplifying the Voices of Alzheimer’s, see details below.
5. National Viral Hepatitis Roundtable Calls for Removed HCV Treatment Barriers, click here to view the letter.
6. IVI to Hold Second Methods Summit, click here to learn more.
7. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
8. Emerging Threats in States like CO and ME for Use of Discriminatory Metrics, see details below.
9. Vaccination Equity and Communication, see details below.
10. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
11. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, Asthma, click here to provide patient input.
12. Upcoming Events and Webinars, see details below.
13. Medical Journal Articles, see details below.
14. AHRQ Effective Program Updates, see details below. 

In This Week’s Issue:

1. National Viral Hepatitis Roundtable Calls for Removed HCV Treatment Barriers, click here to view the letter.
2. NCD Letter on H.R. 3, click here to read the letter.
3. PIPC Chairman, Tony Coelho, reiterates PIPC’s Commitment to Nondiscrimination, see details below.
4. Over 85 Disability and Patient Groups Sign Open Letter: Reject Health Policies that Discriminate, see details below.
5. IVI to Hold Second Methods Summit, click here to learn more.
6. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
7. IVI Value Model on Major Depressive Disorder, see details below.
8. Emerging Threats in States like CO and ME for Use of Discriminatory Metrics, see details below.
9. Vaccination Equity and Communication, see details below.
10. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
11. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, Asthma, click here to provide patient input.
12. Upcoming Events and Webinars, see details below.
13. Medical Journal Articles, see details below.
14. AHRQ Effective Program Updates, see details below. 

In This Week’s Issue:
 
1. NCD Letter on H.R. 3, click here to read the letter.
2. PIPC Chairman, Tony Coelho, reiterates PIPC’s Commitment to Nondiscrimination, see details below.
3. Over 85 Disability and Patient Groups Sign Open Letter: Reject Health Policies that Discriminate, see details below.
4. IVI to Hold Second Methods Summit, click here to learn more.
5. Patient Advocates: International Reference Pricing Would Decimate Alzheimer's Disease Research, see details below.
6. IHP: QALYs in the News, see details below.
7. IHP: Advocates Sue To Overturn Trump CMS Approval Of TN Funding Demo, click here to view the article (subscription only).
8. States Rely on Template Legislation that References ICER and Discriminatory Metrics, see details below.
9. IVI Value Model on Major Depressive Disorder, see details below.
10. Emerging Threats in States like CO and ME for Use of Discriminatory Metrics, see details below.
11. Vaccination Equity and Communication, see details below.
12. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
13. ICER's QALY-Based Study Topics: Hypertrophic Cardiomyopathy, Myasthenia Gravis, Atopic Dermatitis, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, click here to provide patient input.
14. Upcoming Events and Webinars, see details below.
15. Medical Journal Articles, see details below.
16. AHRQ Effective Program Updates, see details below.